May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Macular Pigment Density and Distribution in Patients with Macular Telangiectasia
Author Affiliations & Notes
  • H.–M. Helb
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • P. Charbel Issa
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • D. Pauleikhoff
    Department of Ophthalmology, St. Franziskus Hospital, Münster, Germany
  • H.P. N. Scholl
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • F.G. Holz
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • MacTel–Study Group
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Footnotes
    Commercial Relationships  H. Helb, None; P. Charbel Issa, None; D. Pauleikhoff, None; H.P.N. Scholl, None; F.G. Holz, None.
  • Footnotes
    Support  DFG grants: Heisenberg fellowship SCHO 734/2–1; HO 1926/3–1; European Community (EU) FP6, Integrated Project "EVI–GENORET" (LSHG–CT–2005–512036)
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5701. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H.–M. Helb, P. Charbel Issa, D. Pauleikhoff, H.P. N. Scholl, F.G. Holz, MacTel–Study Group; Macular Pigment Density and Distribution in Patients with Macular Telangiectasia . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5701.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the macular pigment optical density (MPOD) and its topographic distribution patterns in type 2 macular telangiectasis (MT). In this rare disease of the parafoveal capillaries, it is unknown if the MPOD is reduced or if its distribution is changed. Therefore, MPOD was measured in patients with type 2 MT and its distribution was topographically correlated with abnormalities detected by other imaging methods.

Methods: : 19 eyes of 10 patients (median age: 63 years; range 48 – 73 years) were included. Patients were examined by means of fundus biomicroscopy, digital fundus photography, best–corrected visual acuity (VA), fluorescein angiography, and optical coherence tomography. MPOD measurements were performed using a modified confocal SLO (HRA, Heidelberg Engineering, Dossenheim, Germany). MP optical density was calculated using the "two–wavelength–method" from autofluorescence (AF) images, which were aquired at two different excitation wavelengths (488nm, 514nm).

Results: : All eyes exhibited the typical clinical features of type 2 MT with angiographically late hyperfluorescence temporal to the fovea without macular edema. VA was reduced in all eyes (median 20/40; range: 20/200 – 20/25). MOPD distribution showed a consistent pattern in all patients with type 2 MT: in exact correspondence to the late hyperfluorescent areas temporal to the fovea revealed by fluorescein angiography, MPOD was significantly reduced.

Conclusions: : There is good topographic correspondence between angiographically visible alterations and reduced MPOD in type 2 MT. These MPOD findings support the notion that in this disease there is apparent assymetry in impairment between the nasal and the temporal parafovea. It remains to be determined why the temporal parafovea is primarily affected in this disease and by what mechanisms macular pigment is depleted in inner neurosensory retinal layers in presence of telangiectatic retinal capillaries.

Keywords: macular pigment • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×